Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

5 High-Yielding Dividend Stocks That Are Bargain Buys: https://g.foolcdn.com/editorial/images/737484/businessman-showing-chart-to-co-worker.jpg
5 High-Yielding Dividend Stocks That Are Bargain Buys

If you're in search of bargain stocks to buy, the healthcare industry is a great place to start looking. The tech sector has been attracting more attention of late due to the hype around artificial

This 1 Problem Could Sink at Least 4 Gene-Editing Stocks: https://g.foolcdn.com/editorial/images/737749/3-worried-investors-talk-at-a-table.jpg
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks

What do CRISPR Therapeutics (NASDAQ: CRSP), Bluebird Bio (NASDAQ: BLUE), Editas Medicine (NASDAQ: EDIT), and Intellia Therapeutics (NASDAQ: NTLA) all have in common? If you said, "They're biotechs

Better Buy: Nano-X Imaging vs. Viking Therapeutics: https://g.foolcdn.com/editorial/images/736872/a-group-of-scientists-looking-at-a-report.jpg
Better Buy: Nano-X Imaging vs. Viking Therapeutics

Viking Therapeutics (NASDAQ: VKTX) and Nano-X Imaging (NASDAQ: NNOX) are two small-cap healthcare companies with lots of potential, but their shares come with some hefty risks. They've also both

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond: https://g.foolcdn.com/editorial/images/737604/scientist-looking-through-microscope-2.jpg
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

There's nothing wrong with owning index funds, but growth stocks by definition outpace the revenue or profit of a typical stock, which likely results in greater gains than index funds can produce.

Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks: https://g.foolcdn.com/editorial/images/737483/a-person-holding-money.jpg
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks

Whether you're saving for retirement, want to set aside money for travel, or just want to give yourself a raise, dividend stocks can help give you some extra income to accomplish those goals. Plus

EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme
EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme
Why Catalent Stock Flopped Today: https://g.foolcdn.com/editorial/images/737986/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
Why Catalent Stock Flopped Today

It seems Catalent (NYSE: CTLT) was apparently the reason why a key drug was refused approval by the Food and Drug Administration (FDA).

According to a media report from a leading financial news

Why Shares of Axsome Therapeutics Fell Wednesday: https://g.foolcdn.com/editorial/images/737958/doctors-white-coat-healthcare-1.jpg
Why Shares of Axsome Therapeutics Fell Wednesday

Shares of Axsome Therapeutics (NASDAQ: AXSM) were down more than 10% as of 3:45 p.m. ET Wednesday after the company announced it is offering 3 million shares at $75 each in a stock sale worth $225

Better Artificial Intelligence Stock: GSK or Eli Lilly?: https://g.foolcdn.com/editorial/images/737932/ai-healthcare.jpg
Better Artificial Intelligence Stock: GSK or Eli Lilly?

Late last year, Open AI's ChatGPT introduced the wider world to the immense power of artificial intelligence (AI). However, pharmaceutical companies have been experimenting with various forms of

Will AT&T Be a Trillion-Dollar Stock by 2050?: https://g.foolcdn.com/editorial/images/737851/att_retail_chicago.jpg
Will AT&T Be a Trillion-Dollar Stock by 2050?

AT&T (NYSE: T) is one of the largest telecom companies in the United States, but it only has a market cap of about $110 billion. That makes it much smaller than the tech titans that have entered the

As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock: https://g.foolcdn.com/editorial/images/737871/space-getty-star-rising-2018_05_10-12_39_51-utc.jpg
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock

The stock market has treated investors well so far in 2023, and although the past couple of weeks have been a bit more turbulent, the Nasdaq Composite (NASDAQINDEX: ^IXIC) gave Wall Street a gain of

What Will AbbVie Buy Next?: https://g.foolcdn.com/editorial/images/737846/ma.jpg
What Will AbbVie Buy Next?

AbbVie (NYSE: ABBV) is facing a tough year ahead. The company's blockbuster drug Humira, which treats various autoimmune conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease, will

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Under-the-Radar Biotech Stocks to Buy in 2023: https://g.foolcdn.com/editorial/images/737101/elderly-person-sitting-on-a-bed.jpg
2 Under-the-Radar Biotech Stocks to Buy in 2023

There are plenty of well-known biotech giants that look like solid investments. But targeting smaller and relatively unknown companies in the industry could provide much juicier returns over the

Why Viking Therapeutics Is Plunging Today: https://g.foolcdn.com/editorial/images/737709/downward-trend.jpg
Why Viking Therapeutics Is Plunging Today

Clinical-stage biotech Viking Therapeutics (NASDAQ: VKTX) is having another tough trading session. As of 1:40 p.m. ET Tuesday, Viking's stock was down by 19.8% on higher-than-normal volume

Snowflake and Nvidia Partner to Create an Unstoppable AI Superteam: https://g.foolcdn.com/editorial/images/737718/snowflake-nvidia-ai.jpg
Snowflake and Nvidia Partner to Create an Unstoppable AI Superteam

On Monday, Snowflake (NYSE: SNOW) and Nvidia (NASDAQ: NVDA) announced a partnership at the Snowflake Summit 2023. "Snowflake's partnership with NVIDIA will bring high-performance machine learning

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
Why Viking Therapeutics Stock Is Crashing Today: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png
Why Viking Therapeutics Stock Is Crashing Today

Viking Therapeutics' (NASDAQ: VKTX) shares were down by 9.9% on heavy volume as of 11:14 a.m. ET on Monday. This sizable drop was due to Pfizer's (NYSE: PFE) announcement that it will advance its

Why Shares of Structure Therapeutics Rose Monday: https://g.foolcdn.com/editorial/images/737621/scientists-examine-cell-make-up-microscope-biotech.jpg
Why Shares of Structure Therapeutics Rose Monday

Shares of Structure Therapeutics (NASDAQ: GPCR) closed up 18.35% on Monday after the clinical-stage biotech received what is perceived to be good news from Pfizer and a boost from an analyst. The

Why Amgen Stock Slumped on Monday: https://g.foolcdn.com/editorial/images/737620/person-in-a-lab-looking-through-a-microscope.jpg
Why Amgen Stock Slumped on Monday

Amgen (NASDAQ: AMGN) stock came under renewed pressure on Monday, several days after more regulators piled on to block a major acquisition announced by the company. The immediate catalyst was a

Why Pfizer Stock Is Tanking Today: https://g.foolcdn.com/editorial/images/737548/weight-loss-pills.jpg
Why Pfizer Stock Is Tanking Today

Pfizer (NYSE: PFE) is having a rough session in early trading Monday. Specifically, the drugmaker's shares were down by 5.5% on heavy volume as of 10:24 a.m. ET Monday morning. 

The big dip came

2 Low-Priced Stocks That Could Make You Richer: https://g.foolcdn.com/editorial/images/737536/thumbnail_oral-medications.jpg
2 Low-Priced Stocks That Could Make You Richer

Buying low-priced growth stocks ($10 or below) can be risky. Companies with bargain-basement share prices tend to have weak balance sheets, highly uncertain outlooks, and limited financing

Is GSK a Strong Buy Right Now?: https://g.foolcdn.com/editorial/images/737534/pills-dollar-symbol.jpg
Is GSK a Strong Buy Right Now?

Dividend-paying pharmaceutical stocks have an outstanding track record of producing market-beating returns on capital. The core reason is that major drug manufacturers tend to generate enormous free

Better Recovery-Story Buy: Emergent BioSolutions or Invitae?: https://g.foolcdn.com/editorial/images/737334/gettyimages-1147525564.jpg
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?

Sometimes, a company hits a stumbling block -- or several of them. The stock plummets, and investors lose faith. But, in some cases, these down-on-their luck companies are able to turn things

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc